A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies-Reference-Cited by-同舟云学术

A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies

Published:2011-04-01 Issue:9 Volume:46 Page:857-869
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr. Pulmonol.

Author:

Taylor Chelsea,Commander Clayton W.,Collaco Joseph M.,Strug Lisa J.,Li Weili,Wright Fred A.,Webel Aaron D.,Pace Rhonda G.,Stonebraker Jaclyn R.,Naughton Kathleen,Dorfman Ruslan,Sandford Andrew,Blackman Scott M.,Berthiaume Yves,Paré Peter,Drumm Mitchell L.,Zielenski Julian,Durie Peter,Cutting Garry R.,Knowles Michael R.,Corey Mary

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference25 articles.

1. Update on gene modifiers in cystic fibrosis;Collaco;Curr Opin Pulm Med,2008

2. Genetic modifiers of lung disease in cystic fibrosis;Drumm;N Engl J Med,2005

3. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis;Hull;Thorax,1998

4. Heritability of lung disease severity in cystic fibrosis;Vanscoy;Am J Respir Crit Care Med,2007

5. Jointly modeling the relationship between survival and pulmonary function in cystic fibrosis patients;Schluchter;Stat Med,2002

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA-Sequencing Co-Expression Analysis with CFTR in Lung Tissue;2024-05-17

2. A robust association test leveraging unknown genetic interactions: Application to cystic fibrosis lung disease;2023-06-24

3. Who Modifies the Modifiers: A High-Resolution View of the Genetic Modifiers of Cystic Fibrosis;American Journal of Respiratory and Critical Care Medicine;2023-05-15

4. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry;Annals of the American Thoracic Society;2023-04

5. Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany;Respiration;2023